World Investment Advisors Has $2.44 Million Stock Holdings in Sanofi (NASDAQ:SNY)

World Investment Advisors grew its holdings in shares of Sanofi (NASDAQ:SNY) by 4.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,544 shares of the company’s stock after buying an additional 2,114 shares during the quarter. World Investment Advisors’ holdings in Sanofi were worth $2,438,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Synergy Asset Management LLC bought a new stake in Sanofi during the 4th quarter worth approximately $25,000. McClarren Financial Advisors Inc. grew its holdings in Sanofi by 952.6% during the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after buying an additional 543 shares in the last quarter. Lee Danner & Bass Inc. purchased a new stake in Sanofi in the 4th quarter valued at $31,000. Sunbelt Securities Inc. lifted its stake in Sanofi by 72.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after acquiring an additional 313 shares in the last quarter. Finally, Sierra Ocean LLC purchased a new position in Sanofi during the 4th quarter worth $44,000. 14.04% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on SNY shares. The Goldman Sachs Group initiated coverage on shares of Sanofi in a report on Friday, March 21st. They issued a “neutral” rating and a $65.00 target price for the company. Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. Deutsche Bank Aktiengesellschaft raised Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Finally, StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Three equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $62.50.

Sanofi Stock Down 4.8 %

Sanofi stock opened at $51.98 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.46 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $131.92 billion, a P/E ratio of 20.88, a P/E/G ratio of 1.01 and a beta of 0.57. The firm has a 50 day moving average price of $55.37 and a 200-day moving average price of $52.71. Sanofi has a twelve month low of $45.22 and a twelve month high of $60.12.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. As a group, equities analysts predict that Sanofi will post 4.36 EPS for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.